NCT05006456 - Real-world Experience of Catheter Ablation Using Novel Ablation Technologies for the Treatment of Atrial Fibrillation | Biotech Hunter

Enrollment

4,000

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

January 30, 2026

Conditions

Paroxysmal Atrial FibrillationPersistent Atrial Fibrillation

Interventions

DEVICE

Catheter ablation

Subjects will undergo catheter ablation using the new technologies, including THERMOCOOL SMARTTOUCH® SF catheter with Visitag SURPOINT, QDOT catheter and HELIOSTAR catheter when they are used in conjunction with Carto system for AF ablations.